0001213900-11-001408.txt : 20110318 0001213900-11-001408.hdr.sgml : 20110318 20110318163939 ACCESSION NUMBER: 0001213900-11-001408 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110131 FILED AS OF DATE: 20110318 DATE AS OF CHANGE: 20110318 EFFECTIVENESS DATE: 20110318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHINA ADVANCED MEDITECH, INC CENTRAL INDEX KEY: 0001445193 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 753269052 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53418 FILM NUMBER: 11698742 BUSINESS ADDRESS: STREET 1: ROOM 405,4/F, WING MING INDUSTRIAL CTR STREET 2: 15 CHEUNG YUE STREET, CHEUNG SHA WAN CITY: KOWLOON STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-6121-8865 MAIL ADDRESS: STREET 1: ROOM 405,4/F, WING MING INDUSTRIAL CTR STREET 2: 15 CHEUNG YUE STREET, CHEUNG SHA WAN CITY: KOWLOON STATE: K3 ZIP: 00000 NT 10-Q 1 extf10q0111_chinaadvance.htm QUARTERLY REPORT EXTENSION extf10q0111_chinaadvance.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
OMB APPROVAL
OMB Number: 3235-0058
Expires: November 30, 2012
Estimated average burden hours per response ... 2.50
 
SEC FILE NUMBER
000-53418
 
CUSIP NUMBER
 
 
(Check one):
  
o Form 10-K o  Form 20-F o  Form 11-K  xForm 10-Q o  Form 10-D o  Form N-SAR o  Form N-CSR
     
   
For Period Ended:
January 31, 2011
     
   
o   Transition Report on Form 10-K
     
   
o   Transition Report on Form 20-F
     
   
o   Transition Report on Form 11-K
     
   
o   Transition Report on Form 10-Q
     
   
o   Transition Report on Form N-SAR
     
   
For the Transition Period Ended:
 
 
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 
PART I — REGISTRANT INFORMATION
 
 
CHINA ADVANCED MEDITECH, INC.
Full Name of Registrant
 
 
Former Name if Applicable
 
 
Room 405, 4/F., Wing Ming Industrial Centre
Address of Principal Executive Office (Street and Number)
 
 
15 Cheung Yue Street, Cheung Sha Wan, Kowloon, Hong Kong
City, State and Zip Code

 
 
 
 
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 
x
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

x
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
 
o
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE
 
Registrant was not able to obtain all information prior to filing date and the accountant could not complete the required financial statements and management could not complete Management's Discussion and Analysis of such financial statements by March 17, 2011.
 
PART IV — OTHER INFORMATION
(1)
  
Name and telephone number of person to contact in regard to this notification
         
Wong Wa Kei Anthony
  
(852)
  
61218865
(Name)
  
(Area Code)
  
(Telephone Number)
             
 
(2)
  
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
   
Yesx     No o
     
(3)
  
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
   
Yes o     Nox
     
   
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
     
 
 
 
 
 
CHINA ADVANCED MEDITECH, INC.
(Name of Registrant as Specified in Charter)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

             
Date:
  
March 17, 2011
  
By:
  
/s/ Wong Wa Kei Anthony
           
President, Secretary,
Chief Financial Officer and Director